Convatec Executive Leadership Team

Karim joined Convatec in September 2019. Previously, he was CEO of Genus plc, a leading global agricultural biotechnology company. During his eight-year tenure, he helped transform Genus into a technology pioneer with leading global franchises in dairy, beef and pork genetics. Prior to this, Karim worked for over 15 years with Eli Lilly & Company and was President of Lilly Europe, Canada and Australia. An ex-McKinsey & Company consultant, he has worked across Asia and Europe, and also held management roles in the US with Johnson & Johnson and the Dow Chemical Company.

Karim was a Non-Executive Director of Spectris Plc, a leading global analytical instrumentation company, from 2017 to 2021, and is a member of the University of Michigan Ross School of Business Advisory Board.   

Karim has a Masters (Hons) in Business Administration, University of Michigan, Ross School of Business and a Bachelor of Science in Biochemistry, University of Wisconsin.

Jonny Mason joined Convatec Group on 31 January 2022 and was appointed CFO from 12 March 2022 when he joined the Board of the global medical solutions company.

An engineer and accountant by training, Jonny is a seasoned CFO with an extensive track record in listed and international businesses and brings diverse strategic enterprise transformation, deep financial acumen and a customer orientation. Prior to joining Convatec, Jonny was Chief Financial Officer of Dixons Carphone Plc, now known as Currys Plc, between 2018-2021. At Dixons, he played a central role in the company’s transformation, growth and development of its omnichannel capability.

A talented people-leader, he has made a significant contribution to businesses he has been a part of, particularly those going through transformation, where he has delivered a stronger balance sheet, a sharp focus on cash and cost control as well as in building and contributing to high performing teams. Previous roles include CFO of Halfords Plc from 2015 and he was their interim CEO between September 2017 and January 2018. Jonny has built up a diverse and strong portfolio of experience, including being CFO of Scandi Standard AB, CFO at Odeon and UCI Cinemas and Finance Director of Sainsbury’s Supermarkets. His early career included finance roles with Shell and Hanson Plc.

David joined Convatec in November 2018. He was previously at Johnson and Johnson for 26 years, where he held a variety of sales, marketing, strategic and operations roles. Most recently he was the Vice President, Southern EMEA with responsibility for 15 businesses across the region.  Prior to that he was the US President for Cardiovascular and Specialty Services.

David holds a Diploma in Marketing and a BSc in Management Science from the University of Lancaster.

Bruno joined Convatec in August 2005 and has a diverse range of experience across Sales, Business Development & Global Emerging Markets. He was previously Head of our Latin America business before being promoted to an interim role of President & COO, Global Emerging Markets in September 2021. In May 2022 Bruno took over the position of President & Chief Operating Officer, Ostomy Care.  Prior to joining Convatec he worked for Bristol Myers Squibb from April 2005 until its sale of Convatec later that year.

In his former role, Bruno led a diverse team operating across eight countries and drove significant growth and expansion for the sub region. A key area of development has been the launch of seven Convatec Medical Care clinics throughout various countries in Latin America. Bruno was also responsible for achieving ‘Great Place to Work’ recognition for multiple markets within the region, demonstrating the importance of our values as an employer.

Bruno graduated with a Bachelor’s degree in Marketing & Advertising and a Master’s degree in Business Administration from Getúlio Vargas Business School, São Paulo, Brazil.

Seth joined Convatec in September 2017 following the acquisition of Woodbury Health Products, where he served as CEO for five years. He became a CELT member in January 2020 with responsibility for our Home Services Group. In January 2022, he added to those responsibilities as President & Chief Operating officer for both Continence Care and Home Services Group.

Prior to Convatec, Seth served at Cantel Medical Corp as an EVP for a decade - a New York Stock Exchange listed specialty healthcare company dedicated to Infection Prevention and Control. Seth has lived and worked in North America, Asia and Europe holding positions in investment banking, management consulting, and as head of operations for a global media research firm.

Seth holds an MBA from the Harvard Graduate School of Business Administration and a Bachelor of Arts Degree in Mathematics with honors from the University of Pennsylvania.

Kjersti joined Convatec in January 2018 as President EMEA, and from February 2020, became President & Chief Operating Officer, Continence Care. In January 2022, she was appointed President & Chief Operating Officer, Infusion Care. Kjersti also has CELT-level responsibility for our Marketing Centre of Excellence.

Prior to Convatec, she was President Europe and the Middle East and President International, at Alere, Inc. Kjersti was a member of the founding team at Axis-Shield, which was acquired by Alere in 2011. Kjersti’s 25 years of experience in the medical technology sector includes over two decades in roles within diabetes care, including General Manager, Operations, Sales, Marketing and R&D positions.

Kjersti holds a Master of Science in Biotechnology from the Norwegian University of Science and Technology.

Anne Belcher joined Convatec on 18 April 2022 as President & Chief Operating Officer, Global Emerging Markets. 

Anne joined the business after 30 years at GlaxoSmithKline (GSK), where she most recently served as Senior Vice President & General Manager, Nordics. She originally joined GSK as a sales representative in New Zealand in 1991.

Anne has extensive experience in diverse market environments, including both mature and emerging markets across Asia Pacific, EMEA and the Americas. Her previous roles at GSK include SVP, Respiratory, Customer Capabilities and Operations, US (2019-2021); VP, General Manager in Australia (2016-2019); VP, Ethics and Compliance across Emerging Markets, Asia Pacific and Japan (2015-2016), General Manager of GSK’s Indonesian business (2011-15).

An outstanding people leader, she has built successful, compliant and effective teams that are results orientated, with a solid sales and commercial focus.

Originally from New Zealand, Anne is a pharmacist. Anne lives with her husband in Singapore.

John Haller joined Convatec on 1 April 2022 to lead our Global Quality and Operations Team.

John joined Convatec from Next Press, a contract manufacturing and packaging distribution business with operations across North America. At Next Press, he was General Manager from 2019 and drove margin expansion and customer diversification while strengthening their supply chain. Previously, he spent twenty-six years with Stryker Corporation, a leading global medical technologies business where he managed the company’s global supply chain with more than 12,000 employees across 43 locations in North America, Europe and Asia.

A seasoned operations leader, John has lived and worked in countries around the world while helping Stryker grow from a $1 billion revenue company to a $13 billion revenue company. He is a US Army veteran where he served as a member of a global rapid deployment force.

John is based in our Switzerland office.

Divakar joined Convatec in January 2020. Prior to joining he was Chief Digital Officer and Vice President for Eli Lilly’s Drug Delivery, Device and Digital Health groups, where he led a global R&D team focused on developing innovative and digitally-enabled devices to improve patient care. Divakar’s career in healthcare spans more than 20 years. During this time, in addition to working in product development, he has built strong expertise in process development. He served as Eli Lilly’s Vice President of Manufacturing Science and Technology, a role in which he oversaw all the company’s process development across its entire product portfolio.

Divakar holds a PhD in Chemical Engineering from Pennsylvania State University and a Bachelor of Technology degree in Chemical Engineering from Anna University in India. He also holds an MBA from Harvard Business School.

Evy joined Convatec in November 2020 as Chief of Corporate Strategy and Business Development and in April 2021 assumed the roles of General Counsel and Company Secretary. Evy has deep expertise in the MedTech sector, having spent twenty years at Becton, Dickinson and Company prior to joining Convatec.  At BD, she was Senior Vice President of Corporate Development and Strategy and whilst there she helped the company build its capabilities around corporate development & strategy and assisted the global business units in strengthening their strategic focus and pursuing opportunities for partnerships, acquisitions and divestitures. Prior to her role in corporate development at BD, Evy held positions of increasing responsibility in the BD Law Group. She began her career at White & Case in New York.  

Evy holds a Juris Doctor Degree from Harvard Law School and a Bachelor’s with Honors in Political Science from Williams College, Massachusetts, U.S.

Emma Rose joined Convatec on 8 April 2024. She was previously Chief Human Resources Officer at Travis Perkins plc, the UK’s largest distributor of building materials with more than 20,000 colleagues in the UK and Europe. Prior to this, Emma held senior HR roles at Kerry Foods, InterContinental Hotels Group and Mondelēz International.

She is a seasoned HR leader with over 20 years’ experience and a strong track record for delivering transformational people and culture strategies.

Emma holds a BSc in Management Studies from Brunel University. She is currently a Non Executive Board Member of Special Olympics Great Britain.